Back to News
Market Impact: 0.15
Wednesday 10/21 Insider Buying Report: BOLD, OWLS
Source: Nasdaq
Insider TransactionsHealthcare & Biotech
Boundless Bio insider Kevin Tang bought $349,593 of BOLD shares on Tuesday; the article excerpt says he purchased 14 shares but cuts off before providing the full quantity or further details. The reported insider purchase is a modest positive signal, but the excerpt provides no information about the second buy or any market reaction.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.15
Ticker Sentiment
BOLD0.35
More News
- Sovereign wealth funds' China and Hong Kong investments surge 190% after a bruising slump
- Arcus Biosciences prices $250 million stock offering at $17.50
- AstraZeneca says U.S. FDA approves rare kidney disease drug
- UnitedHealth's Earnings Jumped 60%. Is the Comeback Stock a Buy, Sell, or Hold?
- Moderna is about to release the trial results for its cancer vaccine. A lot is riding on this data.
- Why is Intuitive Surgical stock tumbling today?